Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Sold as Hydrocortone. Every FDA application for this active ingredient: 1 branded and 1 generic.
As of Nov 15, 2026, FDA lists 2 applications for Hydrocortisone Sodium Phosphate (sold as Hydrocortone), first approved Jun 8, 1960, with 0 new uses approved and 0 published complete response letters.
First approved: Jun 8, 1960
Applications: 2
New uses approved: 0
Complete response letters: 0
First approved in the EU: Nov 3, 2011
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
HYDROCORTISONE 1% CREAM: $0.120 per GMGeneric · +7% in a year
HYDROCORTISONE 1% OINTMENT: $0.147 per GMGeneric · -2% in a year
HYDROCORTISONE 1%-ACETIC ACID 2% EAR DROP: $5.90 per MLGeneric · -3% in a year
HYDROCORTISONE 10 MG TABLET: $0.183 per unitGeneric · -19% in a year
HYDROCORTISONE 100 MG/60 ML: $0.143 per MLGeneric · -4% in a year
HYDROCORTISONE 2.5% CREAM: $0.103 per GMGeneric · -8% in a year
HYDROCORTISONE 2.5% LOTION: $0.226 per MLGeneric · +4% in a year
HYDROCORTISONE 2.5% OINTMENT: $0.092 per GMGeneric · -7% in a year
HYDROCORTISONE 20 MG TABLET: $0.299 per unitGeneric · -24% in a year
HYDROCORTISONE 5 MG TABLET: $0.139 per unitGeneric · -2% in a year
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA